🇺🇸 Measles, mumps, rubella vaccine in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 16

Most-reported reactions

1. Chest Pain — 2 reports (12.5%)
2. Cough — 2 reports (12.5%)
3. Dyspnoea — 2 reports (12.5%)
4. Face Oedema — 2 reports (12.5%)
5. Loss Of Consciousness — 2 reports (12.5%)
6. Malaise — 2 reports (12.5%)
7. Abdominal Pain — 1 report (6.25%)
8. Ageusia — 1 report (6.25%)
9. Alveolar Aeration Excessive — 1 report (6.25%)
10. Amnesia — 1 report (6.25%)

Source database →

Frequently asked questions

Is Measles, mumps, rubella vaccine approved in United States?

Measles, mumps, rubella vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Measles, mumps, rubella vaccine in United States?

PATH is the originator. The local marketing authorisation holder may differ — check the official source linked above.